The session allowed citizens and pharmaceutical-sector representatives to raise questions about licensing, medicines and regulatory services, with DRAP officials providing clarifications on the issues discussed.
The session allowed citizens and pharmaceutical-sector representatives to raise questions about licensing, medicines and regulatory services, with DRAP officials providing clarifications on the issues discussed.